Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
1.1140
-0.1700
(-13.24%)
As of 3:29:02 PM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-137,302
-137,302
-63,826
-53,204
-63,806
Investing Cash Flow
-61,794
-61,794
-51,355
-161,985
-26,939
Financing Cash Flow
64,734
64,734
-13,715
622,905
158,577
End Cash Position
220,536
220,536
356,778
487,840
80,863
Capital Expenditure
-27,290
-27,290
-27,795
-30,817
-26,472
Issuance of Capital Stock
71,597
71,597
3,751
642,144
163,955
Repayment of Debt
--
--
-9,500
--
--
Free Cash Flow
-164,592
-164,592
-91,621
-84,021
-90,278
12/31/2020 - 10/4/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BV3A.F Bavarian Nordic A/S
7.20
-3.36%
ZVA.F Cellectis S.A.
1.2780
-0.62%
22Z.F Zealand Pharma A/S
80.30
-0.93%
AYJ.F Valneva SE
3.2680
-3.88%
CVAC CureVac N.V.
2.9850
-3.08%
ALNY Alnylam Pharmaceuticals, Inc.
238.82
-1.93%
RVMD Revolution Medicines, Inc.
37.50
-2.19%
MESO Mesoblast Limited
14.27
-7.37%
BEAM Beam Therapeutics Inc.
24.63
-1.89%
AXSM Axsome Therapeutics, Inc.
122.87
-3.37%